APOE and Alzheimer disease: This exploratory finding, which should be confirmed in more prospective studies with adequate statistical power, suggests that the APOE genotype modulates the associations between DHA and incident AD, and reinforces the need to target these particular individuals for supplementation, as expanded upon below.